Frontline immunotherapy combined with radiation and chemotherapy in high-risk endometrial cancer (FIERCE)

Authors

• Christina Washington, University of Oklahoma, Oklahoma City, OK
• Tara Castellano, LSU Health Sciences Center - New OrleansFollow
• Lisa Landrum, Indiana University, Indianapolis, IN
• Robert Mannel, University of Oklahoma, Oklahoma City, OK
• Debra Richardson, University of Oklahoma Health Sciences Center, Oklahoma City, OK
• Laura Holman, University of Oklahoma Health Sciences Center, Oklahoma City, OK
• Joan Walker, University of Oklahoma, Oklahoma City, OK
• Kathleen Moore, University of Oklahoma, Oklahoma City, OK

Document Type

Conference Proceeding

Publication Date

9-1-2025

Publication Title

Gynecologic Oncology

Abstract

Society of Gynecologic Oncology (SGO) 2025 Annual Meeting on Women's Cancer, March 14-17, 2025, Seattle, WA

First Page

72

Volume

200

Issue

Supplement 1

Comments

Abstract Number: 207

Rights

© 2025 Elsevier Inc.

Recommended Citation

Washington, Christina; Castellano, Tara; Landrum, Lisa; Mannel, Robert; Richardson, Debra; Holman, Laura; Walker, Joan; and Moore, Kathleen, "Frontline immunotherapy combined with radiation and chemotherapy in high-risk endometrial cancer (FIERCE)" (2025). School of Medicine Faculty Publications. 4541.
https://digitalscholar.lsuhsc.edu/som_facpubs/4541
10.1016/j.ygyno.2025.04.054